Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

THYHOLM FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   0.8% 0.8% 0.8% 1.2% 1.7% 1.4% 9.9% 9.9%   Credit score (0-100)   93 94 91 81 72 77 25 25   Credit rating   AA AA AA A A A BB BB   Credit limit (kDKK)   302.7 301.9 278.3 72.1 2.5 22.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,728 1,702 1,634 1,632 1,396 1,515 0.0 0.0   EBITDA   798 489 486 364 203 291 0.0 0.0   EBIT   644 372 307 181 20.0 122 0.0 0.0   Pre-tax profit (PTP)   637.8 376.0 304.5 156.9 -19.7 60.9 0.0 0.0   Net earnings   496.7 291.8 237.2 57.9 -15.9 46.2 0.0 0.0   Pre-tax profit without non-rec. items   638 376 304 157 -19.7 60.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   3,151 3,100 3,765 3,819 3,686 3,818 0.0 0.0   Shareholders equity total   2,842 2,934 2,971 2,829 2,613 2,659 2,534 2,534   Interest-bearing liabilities   724 570 652 995 1,065 1,171 0.0 0.0   Balance sheet total (assets)   3,796 3,958 4,034 4,044 3,854 4,006 2,534 2,534   Net Debt   628 560 650 993 1,063 1,120 -2,534 -2,534     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,728 1,702 1,634 1,632 1,396 1,515 0.0 0.0   Gross profit growth   -1.9% -1.5% -4.0% -0.1% -14.5% 8.5% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,796 3,958 4,034 4,044 3,854 4,006 2,534 2,534   Balance sheet change%   7.7% 4.3% 1.9% 0.3% -4.7% 4.0% -36.7% 0.0%   Added value   797.8 489.4 486.4 364.1 202.9 290.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -85 -218 436 -178 -366 -62 -3,818 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   37.2% 21.9% 18.8% 11.1% 1.4% 8.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   17.8% 9.9% 7.9% 4.5% 0.5% 3.1% 0.0% 0.0%   ROI %   18.4% 10.6% 8.6% 4.7% 0.5% 3.2% 0.0% 0.0%   ROE %   18.8% 10.1% 8.0% 2.0% -0.6% 1.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   74.9% 74.1% 73.7% 70.0% 67.8% 66.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   78.7% 114.5% 133.6% 272.8% 524.2% 385.4% 0.0% 0.0%   Gearing %   25.5% 19.4% 21.9% 35.2% 40.8% 44.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.5% 1.4% 1.9% 3.0% 3.9% 5.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.5 2.3 0.5 0.2 0.2 0.2 0.0 0.0   Current Ratio   1.5 2.3 0.5 0.2 0.2 0.2 0.0 0.0   Cash and cash equivalent   95.4 9.1 1.9 1.9 1.9 50.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   142.2 381.6 -166.5 -467.8 -587.7 -677.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   399 245 243 182 101 145 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   399 245 243 182 101 145 0 0   EBIT / employee   322 186 153 91 10 61 0 0   Net earnings / employee   248 146 119 29 -8 23 0 0